Archived story2 articles · 2 publishers
GLP-1 drugs reshape fast-food menus; Novo's next-gen drug beats Zepbound
- Published
- Updated
- Reports
- 2 from 2 publishers
Restaurant chains like Chipotle, McDonald's, and Shake Shack are revamping their menus as more consumers use GLP-1 weight-loss drugs. Separately, Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.
AI summary · Original reporting is linked alongside
How the outlets frame it
2 outlets, each read from its own headline and openingTap a logo to see the outlet, the headline it was read from, and where it sits on every measure.
Does the report cast the development as bad news or good news?
CBS News reads as neutral, The Hill as leans positive.
Does the report play the story up to grab attention?
Both read as measured.
Do the words judge rather than describe?
Both read as neutral wording.
Does the report give room to one side only?
CBS News reads as straight, The Hill as one-sided.
All 2 outlets and the headlines they were read from
CBS News
How GLP-1 weight-loss drugs are changing fast-food menusFraming: Neutral · Sensationalism: Measured · Loaded language: Neutral wording · Slant: Straight
The Hill
Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trialFraming: Leans positive · Sensationalism: Measured · Loaded language: Neutral wording · Slant: One-sided
Each outlet is read blind: a classifier sees its headline and opening next to the story's own headline, without the outlet's name, and scores how the report presents the story. A logo sits at the classifier's average reading, so it can fall between two levels. These readings compare coverage of this story only; they are not ratings of the outlets.
The story as a whole
Read from all the reports togetherOngoing trend
Not disputed in the text
No violence reported
Other signals
7 found · 14 not present- Article typeNews report
- TopicHealth and medicine
- What a reader getsNew facts
- ToneNeutral and factual
- Market relevanceRelevant to markets
- Corporate dimensionA product or service
- Public healthA treatment or drug
- Policy areanot present
- Government levelnot present
- Where it happensnot present
- Main political actornot present
- Civil liberties questionnot present
- Which marketnot present
- Market horizonnot present
- Who is economically affectednot present
- Conflict dimensionnot present
- Conflict direction reportednot present
- Humanitarian impactnot present
- Public safetynot present
- Scientific evidencenot present
- Legal risk in the reportingnot present
The 10 stories everyone is covering, in your inbox at 7 am your time.
grouped.news is free, independent and has no paywall. If it saves you time, chip in.Buy us a coffee ↗